Medpace Holdings (MEDP) Net Cash Flow (2015 - 2026)

Medpace Holdings has reported Net Cash Flow for 12 years, with the latest figure at $157.7 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 168.53% year-over-year to $157.7 million; the trailing twelve-month figure through Mar 2026 stood at $209.5 million (up 525.18% YoY), and the FY2025 full-year result was -$178.3 million, down 141.81% from the prior year.
• Net Cash Flow for Q1 2026 stood at $157.7 million, down from $210.9 million in the prior quarter.
• The five-year high for Net Cash Flow was $239.0 million in Q3 2025, with the low at -$398.1 million in Q2 2025.
• Historically, Net Cash Flow has averaged $11.5 million across 5 years, with a median of $17.9 million in 2023.
• Annual changes were most pronounced in 2022 — Net Cash Flow sank 764.14% — and 2023, when it soared 4199.56%.
• Medpace Holdings' Net Cash Flow stood at -$3.7 million in 2022, then soared by 4199.56% to $149.9 million in 2023, then sank by 90.33% to $14.5 million in 2024, then jumped by 1355.04% to $210.9 million in 2025, then decreased by 25.22% to $157.7 million in 2026.
• The last three Net Cash Flow figures came in at $157.7 million (Q1 2026), $210.9 million (Q4 2025), and $239.0 million (Q3 2025), per Business Quant data.